What is the registration number for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM?

CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM is registered under USPTO registration number 7484782.

CON

USPTO Trademark Record

REGISTERED

CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM

Q: Who owns the CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark?

The CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark is owned by Scleroderma Research Foundation.

Q: What class is the CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark registered in?

The CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM?

The USPTO serial number for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM is 97795022.

SN 97795022·Reg 7484782·Filed Feb 14, 2023

Owner Scleroderma Research Foundation

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM (Serial No. 97795022), Registration No. 7484782, is a registered US trademark filed on Feb 14, 2023 by Scleroderma Research Foundation. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: August 27, 2030

Mark Intelligence

CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM (Reg. #7484782) is a registered US trademark that has been protecting its owner, Scleroderma Research Foundation, since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 14, 2023

SERIAL

97795022

REG#

7484782

REGISTERED

Aug 27, 2024

Owner

Applicant

Scleroderma Research Foundation

Entity

Non-Profit Corporation

State

Address

220 Montgomery Street, Suite 484, San Francisco, CA, 94104

Country

Attorney

NameJ. Scott Gerien

Law firm

J. Scott Gerien DICKENSON, PEATMAN & FOGARTY

Address

1500 FIRST STREET, STE 200, NAPA, CA 94559, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 14, 2023

Serial Number97795022

Registration No.7484782

Registration DateAug 27, 2024

Status DateAug 27, 2024

Published for OppositionJun 11, 2024

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 01, 2023

First use in commerce: Feb 01, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

28 events

REGISTERED-PRINCIPAL REGISTER

Aug 27, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 27, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 11, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 11, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 22, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 04, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 03, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 03, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 03, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 11, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 11, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 11, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 05, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jan 04, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 04, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 04, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 04, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 04, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 09, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 08, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 08, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Nov 13, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Nov 13, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 13, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 13, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 07, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 05, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 17, 2023

NEW APPLICATION ENTERED

CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Scleroderma Research Foundation

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by J. Scott Gerien

Resources

Company